Details of the Drug

General Information of Drug (ID: DMHGDOO)

Drug Name
BEL-0222
Indication
Disease Entry ICD 11 Status REF
Neuroblastoma 2D11.2 Phase 1/2 [1]
Cross-matching ID
TTD ID
D05NYK

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)